Eikonoklastes is rapidly advancing innovative medicines for numerous areas of significant unmet medical need.
Eikonoklastes Therapeutics has raised $13.6M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2025.
Eikonoklastes Therapeutics's investors include Rev1 Ventures, CincyTech, JobsOhio, Elk Capital Partners.
Eikonoklastes Therapeutics is headquartered in Cincinnati, United States.
Eikonoklastes is rapidly advancing innovative medicines for numerous areas of significant unmet medical need.
Eikonoklastes Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Eikonoklastes Therapeutics — Funding & Investors." VCBacked, July 27, 2025, https://www.vcbacked.co/company/eikonoklastes-therapeutics. Accessed July 19, 2026.
VCBacked. (2025). Eikonoklastes Therapeutics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/eikonoklastes-therapeutics
{{cite web |title=Eikonoklastes Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/eikonoklastes-therapeutics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated